Targeting cancer stem cell pathways for cancer therapy

L Yang, P Shi, G Zhao, J Xu, W Peng, J Zhang… - Signal transduction and …, 2020 - nature.com
Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been
considered promising therapeutic targets for cancer therapy. These cells have self-renewal …

NAD+ metabolism, stemness, the immune response, and cancer

LE Navas, A Carnero - Signal transduction and targeted therapy, 2021 - nature.com
NAD+ was discovered during yeast fermentation, and since its discovery, its important roles
in redox metabolism, aging, and longevity, the immune system and DNA repair have been …

[HTML][HTML] Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer

L Yang, HJ Xie, YY Li, X Wang, XX Liu… - Oncology …, 2022 - spandidos-publications.com
Cisplatin is one of the most effective chemotherapy drugs for ovarian cancer, but resistance
is common. The initial response to platinum‑based chemotherapy is as high as 80%, but in …

Lipid droplets: platforms with multiple functions in cancer hallmarks

ALS Cruz, EA Barreto, NPB Fazolini, JPB Viola… - Cell death & …, 2020 - nature.com
Lipid droplets (also known as lipid bodies) are lipid-rich, cytoplasmic organelles that play
important roles in cell signaling, lipid metabolism, membrane trafficking, and the production …

The challenge of drug resistance in cancer treatment: a current overview

M Nikolaou, A Pavlopoulou, AG Georgakilas… - Clinical & Experimental …, 2018 - Springer
It is generally accepted that recent advances in anticancer agents have contributed
significantly to the improvement of both the disease-free survival and quality of life in cancer …

Drug resistance driven by cancer stem cells and their niche

M Prieto-Vila, R Takahashi, W Usuba… - International journal of …, 2017 - mdpi.com
Drug resistance represents one of the greatest challenges in cancer treatment. Cancer stem
cells (CSCs), a subset of cells within the tumor with the potential for self-renewal …

[HTML][HTML] GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer

J Lin, T Song, C Li, W Mao - … et Biophysica Acta (BBA)-Molecular Cell …, 2020 - Elsevier
Glycogen synthase kinase-3β (GSK-3β) is an evolutionarily conserved serine/threonine
kinase, functioning in numerous cellular processes including cell proliferation, DNA repair …

Triple-negative breast cancer: current understanding and future therapeutic breakthrough targeting cancer stemness

KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - mdpi.com
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …

Anti-carcinogenic glucosinolates in cruciferous vegetables and their antagonistic effects on prevention of cancers

P Soundararajan, JS Kim - Molecules, 2018 - mdpi.com
Glucosinolates (GSL) are naturally occurring β-d-thioglucosides found across the
cruciferous vegetables. Core structure formation and side-chain modifications lead to the …

Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells

H Rezayatmand, M Razmkhah… - Stem cell research & …, 2022 - Springer
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …